Nonalcoholic steatohepatitis (NASH) has become a major cause of cirrhosis and liver-
related deaths worldwide. NASH is strongly associated with obesity and the metabolic …

Nonalcoholic fatty liver disease (NAFLD) is the liver manifestation of the complex metabolic
derangements associated with obesity. NAFLD is characterized by excessive deposition of …

Non-alcoholic fatty liver disease (NAFLD) is a major public health problem worldwide.
NAFLD (both simple steatosis and steatohepatitis) is characterized by alterations in hepatic …

Non‐alcoholic fatty liver disease (NAFLD) is not a single disease entity, rather it describes a
spectrum of liver conditions that range from fatty liver (steatosis) to more severe steatosis …

Nonalcoholic fatty liver disease (NAFLD) is a progressive liver disease that can progress to
nonalcoholic steatohepatitis (NASH), NASH-related cirrhosis, and hepatocellular carcinoma …

Aims To conduct a systematic literature review to identify recent epidemiological, biomarker,
genetic and clinical evidence that expands our understanding of nonalcoholic fatty liver …

Nonalcoholic fatty liver disease (NAFLD) has recently been recognized as an important
etiology contributing to the increased incidence of hepatocellular carcinoma (HCC). NAFLD …

Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver
dysfunction and a significant global health problem with substantial rise in prevalence over …

Abstract Non Alcoholic Fatty Liver Disease (NAFLD) is currently the most common chronic
liver disease in the world, encompassing various conditions ranging from simple steatosis …

Nonalcoholic fatty liver disease is an increasingly common condition that may progress to
hepatic cirrhosis. This pilot study evaluated the effects of a low-carbohydrate, ketogenic diet …